Okyo PharmaOKYO
13F holders, Q1 2024 (March 31)6holders
$1.49avg. 13F price*
At the end of Q1 2024, 6 institutions reported holding Okyo Pharma Ltd. (OKYO) in their 13F filings. The largest holders were Barclays PLC ($1.3M), Susquehanna International Group, LLP ($30K) and HSBC Holdings PLC ($20K).
- Company
- Okyo Pharma Ltd.
- CUSIP
- G6724L116
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $76 |
| Exits | 2 | $46K |
Ownership 6 holders
| Barclays PLC | 0.00% | Add +12.9% | 855,887 | $1.3M |
| Susquehanna International Group, LLP | 0.00% | Reduce -41.6% | 20,310 | $30K |
| HSBC Holdings PLC | 0.00% | No change | 11,933 | $20K |
| Cerity Partners LLC | 0.00% | Add +8.1% | 13,312 | $20K |
| Geode Capital Management, LLC | 0.00% | No change | 12,090 | $18K |
| Continuum Advisory, LLC | 0.00% | New | 50 | $76 |
"% of holder's portfolio" is OKYO's weight in each manager's 13F, not the share of Okyo Pharma Ltd. the manager owns.